The information contained in these releases was current on the date the releases were issued and will become outdated over time. Lilly does not assume any responsibility for updating information in these releases.
Releases
 |
U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014
Sep 1, 2010
|
7.6 KB |
|
| |
INDIANAPOLIS, Sept 01, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista(R) (raloxifene HCl tablets) are v...
|
|
U.S. District Court Rules Against Lilly Regarding Strattera Patent
Aug 12, 2010
|
8.8 KB |
|
| |
INDIANAPOLIS, Aug 12, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera(R) (atomoxetine). In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled ...
|
|
U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent
Jul 28, 2010
|
8.0 KB |
|
| |
INDIANAPOLIS, July 28, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid.
"We strongly disagree with the ruling b...
|
|
Lilly Announces Completion of Alnara Acquisition
Jul 20, 2010
|
7.8 KB |
|
| |
INDIANAPOLIS, July 20, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of metabolic diseases. The transaction, first announced on July 2, 2010, has received ...
|
|
Lilly to Acquire Alnara Pharmaceuticals
Jul 2, 2010
|
11.3 KB |
|
| |
INDIANAPOLIS and CAMBRIDGE, Mass., July 2, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metab...
|
|
Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
Jun 28, 2010
|
8.7 KB |
|
| |
INDIANAPOLIS, June 28, 2010 /PRNewswire via COMTEX News Network/ -- Marcadia Biotech, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the companies have signed a development and exclusive license agreement for Marcadia's short-acting glucagon program, covering glucagon analogs that may provide greater convenience and ease-of-use tha...
|
|
Olympic XC Skier Kris Freeman Brings Story of Spirit and Tenacity to Campers with Diabetes
Jun 10, 2010
|
11.8 KB |
|
| |
INDIANAPOLIS, June 10, 2010 /PRNewswire via COMTEX News Network/ -- One of the most inspiring personalities of the 2010 Vancouver Games, Olympic cross-country skier Kris Freeman sheds his skis and poles this week to kick off his 6th annual diabetes summer camp tour with Eli Lilly and Company (Lilly Diabetes). Freeman, diagnosed with type 1 diabetes...
|
|
Lilly CEO Addresses America's Innovation Crisis
Jun 9, 2010
|
9.1 KB |
|
| |
DETROIT, June 9, 2010 /PRNewswire via COMTEX News Network/ -- In remarks to the Detroit Economic Club today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, warned that America's greatest competitive advantage--its "genius for innovation"--is in jeopardy. His speech focused on America's historic leadership in innova...
|
|
U.S. District Court Rules on Validity of Lilly's Gemzar Patent
Apr 1, 2010
|
7.4 KB |
|
| |
INDIANAPOLIS, Ind., April 1, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has upheld the validity of the company's compound patent on Gemzar(R) (gemcitabine HCl for injection). This decision maintains Lilly's U.S. exclusivity for Gemz...
|
|
Lilly USA Updates Health Education Program to Help Patients With Depression Build Network of Support
Mar 30, 2010
|
9.4 KB |
|
| |
INDIANAPOLIS, March 30, 2010 /PRNewswire via COMTEX News Network/ -- The Support Partners Program offered by Lilly USA is introducing several updated educational resources for people with depression and the people who care for them.
Each person experiences depression differently and may need support in different ways. The Support Partners Program ...
|
|
Thermo Fisher Scientific and Lilly Announce Expanded Clinical Trial Materials Relationship
Mar 26, 2010
|
11.9 KB |
|
| |
WALTHAM, Mass. & INDIANAPOLIS, Mar 26, 2010 (BUSINESS WIRE) -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, and biopharmaceutical company Eli Lilly and Company (NYSE:
LLY), announced today that they have expanded their clinical trial
materials supply chain relationship. As part of a new fiv...
|
|
Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
Mar 17, 2010
|
12.9 KB |
|
| |
INDIANAPOLIS, March 17, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14.
Lilly is working with the U.S. Food and Drug Administration's Office of Criminal Investigati...
|
|
Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux
Mar 15, 2010
|
9.3 KB |
|
| |
INDIANAPOLIS and MELBOURNE, Australia, March 15, 2010 /PRNewswire via COMTEX News Network/ -- Eli Lilly and Company (NYSE: LLY) and Acrux (ASX: ACR) announced today that they have entered into an exclusive worldwide license agreement for the potential commercialization of Acrux's experimental underarm testosterone solution (proposed tradename AXIRO...
|
|
Lilly to Acquire European Rights to Pfizer Animal Health Assets
Mar 8, 2010
|
7.5 KB |
|
| |
GREENFIELD, Ind., March 8, 2010 /PRNewswire via COMTEX News Network/ -- Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products. The products, including vaccines, parasiticides and feed additive...
|
| Showing 1-14 of 14 |
Page: 1 |
|
|
